Shelter Pharma Ltd Receives GMP Certificate from Gujarat State for Ayurvedic Medicines Manufacturing
Shelter Pharma Limited has received a Good Manufacturing Practices (GMP) Certificate from the Food & Drugs Control Administration, Gujarat State. The certification confirms that the company's manufacturing facility adheres to prescribed standards of Good Manufacturing Practices specific to Ayurvedic medicines.The grant of this certificate, bearing Licence No. GA/12, validates the company's established manufacturing processes and quality control systems. This achievement reflects Shelter Pharma’s commitment to producing high-quality Ayurvedic products through its in-house facilities while strictly adhering to applicable regulatory and quality standards.
The GMP Certificate has been issued under Form 26-E-1 as prescribed by Rule 155-B of the Drugs and Cosmetics Rules, 1945. The certificate covers a wide range of Ayurvedic formulations, enabling the continued production of these products in compliance with regulatory standards.
Key details regarding the GMP certification are outlined below:
| Particulars | Details |
|---|---|
| Regulatory Authority | Food & Drugs Control Administration, Gujarat State |
| Licence/Certificate Number | GA/12 |
| Validity Period | Up to October 2030 |
| Products Covered | Ayurvedic formulations including Churna (Powder), Tablets, Capsules, Syrups, Oral Liquids, Ointments and other approved dosage forms. |
The certification confirms the compliance of the Company's manufacturing facility with prescribed GMP requirements, ensuring the continued production of covered Ayurvedic products in accordance with regulatory standards.
Stock Price Movement
As of 11:42, Shelter Pharma Ltd shares are dipping sharply, currently trading at ₹30.70, which is down 4.00% for the day. The stock has seen very tight movement intraday, having traded between a low of ₹30.70 and a high of ₹30.71.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.